| 中國醫藥大學 |
2007-11-10 |
Hb Westmead Detected by PCR and StuI Restriction Enzyme Methods
|
施浤彰(Hung-Chang Shih); 劉素卿(Su-Ching Liu); 張煜昌(Yu-Chang Chang); 邱燦宏(Tsan-Hung Chiu); 林炯璁(Chiung-Tsung Lin); 林彩秀(Tsai-Hsiu Lin); 張天傑(Tien-Jye Chang); 施木青(Mu-Chin Shih); 彭慶添(Ching-Tien Peng) |
| 亞洲大學 |
2008-06 |
Hb Westmead in a Taiwanese subject: detected by PCR and StuI restriction enzyme methods
|
Lin, T (Lin, T.); Shih, H (Shih, H.); Liu, S (Liu, S.); Chiu, T (Chiu, T.); Chang, Y (Chang, Y.); Lin, C (Lin, C.); Chang, T (Chang, T.); Shih, M (Shih, M.); Peng, C (Peng, C.); Chang, J (Chang, J.) |
| 中國醫藥大學 |
2008-06 |
Hb Westmead in a Taiwanese subject: Detected by PCR and StuI Restriction Enzyme Methods
|
林彩秀(Tsai-Hsiu Lin); 施浤彰(Hung-Chang Shih); 劉素卿(Su-Ching Liu); 邱燦宏(Tsan-Hung Chiu); 張煜昌(Yu-Chang Chang); 林炯璁(Chiung-Tsung Lin); 張天傑(Tien-Jye Chang); 施木青(Mu-Chin Shih); 彭慶添(Ching-Tien Peng); 張建國* |
| 國立臺灣大學 |
1984 |
HB ヨユюЗ保有者ソ產科的管理
|
川名尚; 林鶴雄; 水野正彥; 川名尚; Lin, Ho-Hsiung; 水野正彥 |
| 國立交通大學 |
2014-12-12T01:15:28Z |
HB-2彈體的空氣動力及熱傳模擬
|
柳志良; Chih-Liang Liu; 吳宗信; Jong-Shinn Wu |
| 臺北醫學大學 |
2019-07-03 |
HB-EGF expression in EGFR mutation lung adenocarcinoma cells promoted macrophage polarization toward M2 phenotype
|
NGUYEN VAN HIEP |
| 國家衛生研究院 |
2012-12 |
HbA(1c) variability is associated with microalbuminuria development in type 2 diabetes: A 7-year prospective cohort study
|
Hsu, CC;Chang, HY;Huang, MC;Hwang, SJ;Yang, YC;Lee, YS;Shin, SJ;Tai, TY |
| 國立成功大學 |
2012-12 |
HbA(1c) variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study
|
Hsu, C. C.; Chang, H. Y.; Huang, M. C.; Hwang, S. J.; Yang, Y. C.; Lee, Y. S.; Shin, S. J.; Tai, T. Y. |
| 國立臺灣大學 |
2016 |
HbA1c level is associated with incidence of acid-related upper gastrointestinal disorders
|
Tseng, Ping-Huei; Hung, Chi-Sheng; Lee, Yi-Chia; Chen, Chien-Chuan; Tu, Chia-Hung; Liao, Wei-Chih; Chiu, Han-Mo; Yang, Wei-Shiung; Lin, Jaw-Town; Wu, Ming-Shiang; 林肇堂; 洪啟盛; ?佳宏; 李宜家; 邱瀚模; 楊偉勛; 吳明賢; 陳建全; 廖偉智; 曾屏輝 |
| 中國醫藥大學 |
2012-12 |
HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort
|
許志成;(H. Y. Chang);(M. C. Huang);(S. J. Hwang);(Y. C. Yang);(Y. S. Lee);(S. J. Shin)*;(T. Y. Tai) |
| 高雄醫學大學 |
2007 |
HBcAg-specific CD4(+) CD25(+) regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection.
|
郭樂明;許銘仁;郭行道;孫啟書;李川;莊萬龍;蔡順隆 ; Feng IC;Koay LB;Sheu MJ;Kuo HT;Sun CS;Lee C;Chuang WL;Liao SK;Wang SL;Tang LY;Cheng CJ;Tsai SL |
| 國立臺灣大學 |
1989 |
HBcAg與HBeAg之比較
|
林碧灼; 朱健次; CHU, CHIEN-TS |
| 淡江大學 |
2023-11-04 |
HBcrAg-based risk score performs better than HBV DNA-based score for HCC prediction in HBeAg-negative grey zone patients
|
Chiang, Chieh |
| 國立臺灣大學 |
2012 |
HBeAg(+) and sex ratio of offspring: Evidence form Taiwan's three million newborns
|
Lin, Ming-Jen; Chen, Pei-Jer; Luoh, Ming-Ching; 陳培哲 |
| 臺大學術典藏 |
2021-07-03T03:34:29Z |
HBeAg(+) and sex ratio of offspring: Evidence form Taiwan's three million newborns
|
Lin M.-J.; PEI-JER CHEN; Luoh M.-C. |
| 中國醫藥大學 |
2009-05-02 |
HBeAg-Negative Chronic Hepatitis B 使用 Pegasys 治療經驗之分享
|
賴學洲(Hsueh-Chou Lai) |
| 臺大學術典藏 |
2018-07-06T07:11:04Z |
Hbeag-Negative Chronic Hepatitis B: Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine in Taiwan
|
賴明陽;李全謨; Veenstra, David L.; Sullivan, Sean D.; Lai, Ming-Yang; Lee, Chuan-Mo; Tsai, Chia-Ming; Patel, Kavita K.; Veenstra, David L.; Sullivan, Sean D.; Lai, Ming-Yang; Lee, Chuan-Mo; Tsai, Chia-Ming; Patel, Kavita K. |
| 國立臺灣大學 |
2008 |
Hbeag-Negative Chronic Hepatitis B: Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine in Taiwan
|
賴明陽; 李全謨; LAI, MING-YANG; LEE, CHUAN-MO |
| 國立臺灣大學 |
2014 |
HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?
|
Kao, Jia-Horng; 高嘉宏 |
| 臺大學術典藏 |
2018-09-10T14:59:24Z |
HBeAg-positive chronic hepatitis B: Why do I treat my patients with pegylated interferon?
|
Kao, Jia-Horng; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-09-04T06:11:38Z |
HBeAg-positive chronic hepatitis B: Why do I treat my patients with pegylated interferon?
|
JIA-HORNG KAO |
| 國立臺灣大學 |
2002 |
Hbeag-Positiye Chronic Hepatitis B (Chb) Patients with Difficult-to-Treat Disease Improved Response Rates with Peginterferon Alfa-2a (40kd) ( Pegasys (R)) Compared with Conventional
|
賴明陽; LAI, MING-YANG |
| 國立臺灣大學 |
2008-07-31 |
HBeAg陽性慢性B型肝炎患者HBeAg陰轉過程中病毒因子及脂締素角色之探討
|
劉俊人 |
| 國立成功大學 |
2009-07-03 |
HBeAg陽性慢性B型肝炎患者接受Entecavir的96週治療
|
張定宗 |
| 真理大學 |
2004-05 |
HBGA為基礎之新產品命名系統
|
許芳誠; 郭旭欣; 鍾文卿; 劉用渝; 蔣德凱 |
